Inhibition of mitogenesis and c-fos induction in mesangial cells by heparin and heparan sulfates

Kidney International

Volumn 49, Issue 2, 1996, Pages 437-448

  Wang, Aimin ^a   Templeton, Douglas M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; PHORBOL ESTER; PROTEIN KINASE C;

ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; GENE INDUCTION; MALE; MESANGIUM CELL; MITOGENESIS; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

EID: 0030071194     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.63     Document Type: Article

References (66)

1. CLOWES AW, KARNOVSKY MJ: Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265:625-626, 1977
2. CASTELLOT JJ JR, ADDONIZIO ML, ROSENBERG R, KARNOVSKY MJ: Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol 90:372-379, 1981
3. HOOVER RL, ROSENBERG R, HAERING W, KARNOVSKY MJ: Inhibition of rat arterial smooth muscle cell proliferation by heparin: II. In vitro studies. Circ Res 47:578-583, 1980
4. CASTELLOT JJ JR, COCHRAN DL, KARNOVSKY MJ: Effect of heparin on vascular smooth muscle cells: I. Cell metabolism. J Cell Physiol 124:21-28, 1985
5. CLOWES AW, CLOWES MM, KOCHER O, ROPRAZ P, CHAPONNIER C, GABBIANI G: Arterial smooth muscle cells in vivo: Relationship between actin isoform expression and mitogenesis and their modulation by heparin. J Cell Biol 107:1939-1945, 1988
6. COCHRAN DL, CASTELLOT JJ JR, KARNOVSKY MJ: Effect of heparin on vascular smooth muscle cells: II. Specific protein synthesis. J Cell Physiol 124:29-36, 1985
7. MAJACK RA, BORNSTEIN P: Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells. J Cell Biol 99:1688-1695, 1984
8. MAJACK RA, CLOWES AW: Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 118:253-256, 1984
9. HERMAN IM, CASTELLOT JJ JR: Regulation of vascular smooth muscle cell growth by endothelial-synthesized extracellular matrices. Arteriosclerosis 7:463-469, 1987
10. CASTELLOT JJ JR, PUKAC LA, CALEB BL, WRIGHT TC JR, KARNOVSKY MJ: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 109:3147-3155, 1989
11. PUKAC LA, OTTLINGER ME, KARNOVSKY MJ: Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 267:3707-3711, 1992
12. OTTLINGER ME, PUKAC LA, KARNOVSKY MJ: Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268:19173-19176, 1993
13. REILLY CF, FRITZE LM, ROSENBERG RD: Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells. J Cell Physiol 136:23-32, 1988
14. NUGENT MA, KARNOVSKY MJ, EDELMAN ER: Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res 73:1051-1060, 1993
15. SUN X, MOSHER DF, RAPRAEGER A: Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem 264:2885-2889, 1989
16. MAJACK RA, GOODMAN LV, DIXIT VM: Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 106:415-422, 1988
17. CASTELLOT JJ JR, WONG K, HERMAN B, HOOVER RL, ALBERTINI DF, WRIGHT TC, CALEB BL, KARNOVSKY MJ: Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124:13-20, 1985
18. GUYTON JR, ROSENBERG RD, CLOWES AW, KARNOVSKY MJ: Inhibition of rat arterial smooth muscle cell proliferation by heparin: In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 46:625-634, 1980
19. VANNUCCHI S, PASQUALI F, FIORELLI G, BIANCHINI P, RUGGIERO M: Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites. FEBS Lett 263:137-141, 1990
20. TIOZZO R, CINGI MR, PIETRANGELO A, ALBERTAZZI L, CALANDRA S, MILANI MR: Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types. Arzneim-Forsch 39:15-20, 1989
21. SCOTT-BURDEN T, BUHLER FR: Regulation of smooth muscle proliferative phenotype by heparinoid-matrix interactions. (Review) Trends Pharmacol Sci 9:94-98, 1988
22. PAUL R, HERBERT JM, MAFFRAND JP, LANSEN J, MODAT G, PEREILLO JM, GORDON JL: Inhibition of vascular smooth muscle cell proliferation in culture by pentosan polysulphate and related compounds. Thromb Res 46:793-801, 1987
23. CASTELLOT JJ JR, HOOVER RL, HARPER PA, KARNOVSKY MJ: Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. Am J Pathol 120:427-435, 1985
24. FRITZE L, REILLY CF, ROSENBERG RD: An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol 100:1041-1049, 1985
25. WANG A, FAN MY, TEMPLETON DM: Growth modulation and proteoglycan turnover in cultured mesangial cells. J Cell Physiol 159:295-310, 1994
26. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 24:626-631, 1983
27. LOVETT DH, STERZEL RB: Cell culture approaches to the analysis of glomerular inflammation. Kidney Int 30:246-254, 1986
28. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
29. COFFEY AK, KARNOVSKY MJ: Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury. Am J Pathol 120: 248-255, 1985
30. GAMBARO G, CAVAZZANA AO, LUZI P, PICCOLI A, BORSATTI A, CREPALDI G, MARCHI E, VENTURINI AP, BAGGIO B: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42:285-291, 1992
31. GAMBARO G, VENTURINI AP, NOONAN DM, FRIES W, RE G, GARBISA S, MILANESI C, PESARINI A, BORSATTI A, MARCHI E, BAGGIO B: Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46:797-806, 1994
32. FLOEGE J, ENG E, YOUNG BA, COUSER WG, JOHNSON RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
33. DIAMOND JR, KARNOVSKY MJ: Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol 9:366-374, 1986
34. DOHI K, FUJIOKA M, NAKAMOTO Y: Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis. Acta Pathol Jpn 32:1047-1052, 1982
35. ZVIBEL I, MALAY E, REID LM: Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: Relevance to clonal growth of tumors. Mol Cell Biol 11:108-116, 1991
36. WASTESON Å: A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J Chromatogr 59:87-97, 1971
37. CURRAN T, GORDON MB, RUBINO KL, SAMBUCETTI LC: Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2:79-84, 1987
38. FORT P, MARTY L, PIECHACZYK M, EL SABROUTY S, DANI C, JEANTEUR P, BLANCHARD JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucl Acid Res 13:1431-1442, 1985
39. TEMPLETON DM: The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans. Connect Tissue Res 17:23-32, 1988
40. SIMONSON MS, DUNN MJ: Eicosanoid biochemistry in cultured glomerular mesangial cells. Meth Enzymol 187:544-553, 1990
41. HEGELE RG, BEHAR M, KATZ A, SILVERMAN M: Immunocytochemical characterization of cells in rat glomerular culture. Clin Invest Med 12:181-186, 1989
42. KIMES BW, BRANDT BL: Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98:349-366, 1976
43. JAFFER F, SAUNDERS C, SHULTZ P, THROCKMORTON D, WEINSHELL E, ABBOUD HE: Regulation of mesangial cell growth by polypeptide mitogens: Inhibitory role of transforming growth factor-β. Am J Pathol 135:261-269, 1989
44. REILLY CF, FRITZE LM, ROSENBERG RD: Heparin inhibition of smooth muscle cell proliferation: A cellular site of action. J Cell Physiol 129:11-19, 1986
45. GONG Z: Improved RNA staining in formaldehyde gels. BioTechniques 12:74-75, 1992
46. SHAKLEE PN, CONRAD HE: Hydrazinolysis of heparin and other glycosaminoglycans. Biochem J 217:187-197, 1984
47. THOMPSON J, LAU AL, CUNNINGHAM DD: Selective radiolabeling of cell surface proteins to a high specific activity. Biochemistry 26:743-750, 1987
48. 125I-containing acylating agent. Application to the radioimmunoassay. Biochem J 133:529-539, 1973
49. 3H]heparin to human carcinoma SW-13 and other mammalian cells. Exp Cell Res 187:324-327, 1990
50. LAEMMLI UK: Cleavage of structural proteins during the aasembly of the head of bacteriophage T4. Nature 227:680-685, 1970
51. THOMAS TP, GOPALAKRISHNA R, ANDERSON WB: Hormone- and tumor promoter-induced activation or membrane association of protein kinase C in intact cells. Meth Enzymol 141:399-411, 1987
52. SILBIGER S, CROWLEY S, SHAN Z, BROWNLEE M, SATRIANO J, SCHLONDORFF D: Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kidney Int 43:853-864, 1993
53. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
54. VOLPI N, CUSMANO M, VENTURELLI T: Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. Biochim Biophys Acta Gen Subj 1243:49-58, 1995
55. WRIGHT TC JR, PUKAC LA, CASTELLOT JJ JR, KARNOVSKY MJ, LEVINE RA, KIM-PARK HY, CAMPISI J: Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA 86:3199-3203, 1989
56. REILLY CF, KINDY MS, BROWN KE, ROSENBERG RD, SONENSHEIN GE: Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 264:6990-6995, 1989
57. PUKAC LA, CASTELLOT JJ JR, WRIGHT TC JR, CALEB BL, KARNOVSKY MJ: Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul 1:435-443, 1990
58. REILLY CF: Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin. J Cell Physiol 142:342-351, 1990
59. SAN ANTONIO JD, KARNOVSKY MJ, OTTLINGER ME, SCHILLIG R, PUKAC LA: Isolation of heparin-insensitive aortic smooth muscle cells: Growth and differentiation. Arterioscler Thromb 13:748-757, 1993
60. GOUELI SA, HANTEN JA, AHMED K: Modulation of cofactor requirement for the activation of protein kinase C by heparin: Possible effect at the regulatory domain. FEBS Lett 282:445-448, 1991
61. YAYON A, KLAGSBRUN M, ESKO JD, LEDER P, ORNITZ DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848, 1991
62. ROGHANI M, MOSCATELLI D: Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267:22156-22162, 1992
63. BAME KJ: Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein. J Biol Chem 268:19956-19964, 1993
64. YANAGISHITA M: Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways. J Biol Chem 267:9505-9511, 1992
65. ISHIHARA M, FEDARKO NS, CONRAD HE: Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. J Biol Chem 262:4708-4716, 1987
66. HERBERT JM, MAFFRAND JP: Heparin interactions with cultured human vascular endothelial and smooth muscle cells: Incidence on vascular smooth muscle cell proliferation. J Cell Physiol 138:424-432, 1989